Optimized dual therapy for treatment‐naive patients of Helicobacter pylori infection: A large‐scale prospective, multicenter, open‐label, randomized controlled study

BACKGROUND: The efficacy and safety of high‐dose amoxicillin (AMX) and proton pump inhibitors (PPI) dual therapy raises much more attention in recent years. Comparative studies among the dual therapies are required to explore more suitable regimens. This study compared the efficacy, adverse events,...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Ying‐Ying, Long, Hui, Lin, Ya, He, Qiong, Chen, Wei‐Gang, Ding, Xiang‐Wu, Zhou, Lin, An, Ping, Wang, Fen, Zhang, Zhen‐Yu, Hu, Yun‐Lian, Li, Pei‐Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9541209/
https://www.ncbi.nlm.nih.gov/pubmed/35939559
http://dx.doi.org/10.1111/hel.12922

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9541209/
https://www.ncbi.nlm.nih.gov/pubmed/35939559
http://dx.doi.org/10.1111/hel.12922

Ejemplares similares